Multiple Sclerosis Treatment: Advancing Care for a Complex Neurological Disorder
Multiple Sclerosis (MS) is a chronic, progressive autoimmune disorder that affects the central nervous system (CNS), particularly the brain and spinal cord. Characterized by inflammation, demyelination, and nerve degeneration, MS can lead to a wide range of symptoms including muscle weakness, vision problems, fatigue, and cognitive impairment. With no known cure, treatment focuses on managing symptoms, slowing disease progression, and improving patient quality of life.
Understanding Multiple Sclerosis
MS occurs when the immune system mistakenly attacks the protective myelin sheath covering nerve fibers. This disruption slows or blocks nerve signals, leading to varying neurological symptoms depending on the affected areas. MS is generally classified into four main types:
Relapsing-Remitting MS (RRMS): The most common form, marked by periodic flare-ups followed by periods of remission.
Secondary Progressive MS (SPMS): Initially relapsing-remitting but gradually transitions to continuous neurological decline.